Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Incyte Corporation    INCY

INCYTE CORPORATION

(INCY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on INCYTE CORPORATION
02/09/21 | 01:00pm Jahr 2020 Ergebnisveröffentlichung
02/09/21 | 02:00pm Jahr 2020 Präsentation des Ergebnisses
05/04/21 Q1 2021 Ergebnisveröffentlichung (geplant)
08/03/21 Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant)
Past events on INCYTE CORPORATION
01/11/21 | 01:30pm JP Morgan Healthcare Conference
12/07/20 | 04:00pm American Society of Hematology Meeting
12/01/20 | 04:30pm Evercore ISI HealthCONx Conference
11/11/20 Society of Immunotherapy of Cancer Meeting - Poster Number - 268#
Upcoming sector events for INCYTE CORPORATION
01/27/21 GALAPAGOS NV : Degroof Petercam Healthcare Conference
01/27/21 LONZA GROUP LTD : FY 2020 Earnings Release
01/27/21 | 08:30am LONZA GROUP LTD : FY 2020 Earnings Call
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
More events
Past sector events for INCYTE CORPORATION
01/21/21 | 10:30pm BIOCON LIMITED : Q3 2021 Earnings Call
01/21/21 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/21/21 BIOCON LIMITED : Q3 2021 Earnings Release
01/20/21 | 01:00pm IOVANCE BIOTHERAPEUTICS, INC. : B. Riley Oncology Investor Conference
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread
754
735
2,5%
1 106
1 106
0,00%
1 536
1 520
1,1%
1 882
1 844
2,1%
2 159
2 157
0,10%

2 532
Operating income
(EBITDA)
M $
Released
Forecast
Spread
95,5
23,5
307%
203
213
-4,4%
-192
-171
-12%
184
178
3,2%
457
480
-4,9%

-267
Operating profit
(EBIT)
M $
Released
Forecast
Spread
50,7
17,6
188%
145
158
-8,0%
-244
-209
-17%
129
105
23%
402
409
-1,8%

-302
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
7,56
-33,5
123%
107
124
-14%
-312
-266
-17%
115
120
-3,9%
487
452
7,7%

-267
Net income
M $
Released
Forecast
Spread
6,53
-33,8
119%
104
122
-14%
-313
-269
-17%
109
90,8
21%
447
418
7,0%

-334
EPS
$
Released
Forecast
Spread
0,03
-0,19
116%
0,54
0,62
-13%
-1,53
-1,31
-16%
0,51
0,42
21%
2,05
1,89
8,7%

-1,52
Announcement Date02/11/201602/14/201702/15/201802/14/201902/13/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
552
534
3,2%
579
575
0,78%
569
553
2,8%
688
614
12%
621
622
-0,30%

657
Operating income
(EBITDA)
M $
Released
Forecast
Spread
148
106
40%
108
110
-1,7%


243
211
15%
18,3
129
-86%

138
Operating profit
(EBIT)
M $
Released
Forecast
Spread
134
86,5
55%
95,0
96,2
-1,2%
-664
-652
-1,8%
231
133
73%
5,33
117
-95%

132
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
148
89,3
66%
126
95,9
31%
-704
-690
-2,0%
307
136
126%
-3,51
129
-103%

142
Net income
M $
Released
Forecast
Spread
128
87,6
46%
111
87,0
28%
-721
-666
-8,3%
290
161
80%
-15,2
109
-114%

120
EPS
$
Released
Forecast
Spread
0,59
0,39
51%
0,51
0,35
48%
-3,33
-3,09
-7,9%
1,32
0,66
100%
-0,07
0,50
-114%

0,50
Announcement Date10/29/201902/13/202005/05/202008/04/202011/05/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise